JPJo Ann S Passmore

Jo Ann S Passmore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jo Ann S Passmore has a total of 439 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Happel et al. Cervicovaginal Human Papillomavirus Genomes, Microbiota Composition and Cytokine Concentrations in South African Adolescents. Viruses 2023, 15, 758

    by Anna-Ursula Happel, Christina Balle, Enock Havyarimana, Bryan Brown, Brandon S. Maust, Colin Feng, Byung H. Yi, Katherine Gill, Linda-Gail Bekker, Jo-Ann S. Passmore, et al.

  • Open Access

    Antimicrobial resistance profiles and genomic diversity of vaginal Prevotella bivia isolates from South African women, including the first report of nimK in South African vaginal P. bivia isolates

    by Kirsten Welp, Lynthia Paul, Rémy Froissart, Anna-Ursula Happel, Tanya Pidwell, Katherine Gill, Linda-Gail Bekker, Heather B. Jaspan, Marie Vasse, Jo-Ann S. Passmore, et al.

  • Geographic Variation in Diagnostic Performance of Amsel Criteria and Nugent Score for Vaginal Dysbiosis Defined by 16S rRNA Gene Sequencing

    by Meilin Zhu, Andile Mtshali, Gugulethu Mzobe, Nzuzo Magini, Nireshni Mitchev, Anam Khan, Briah Cooley Demidkina, Meena Murthy, Lara Lewis, Jiawu Xu, et al.

    Background: Vaginal dysbiosis characterized by low abundance of vaginal lactobacilli and increased bacterial community diversity, is implicated in multiple adverse health outcomes and is an emerging target for preventive interventions, including live biotherapeutic products. The most common clinical presentation of vaginal dysbiosis is bacterial vaginosis (BV), but at least half of people are asymptomatic. Methods: We compared identification of BV by Nugent score and Amsel criteria for screening specimens from a Phase 1b randomized trial of a live biotherapeutic product conducted at 2 sites (CAPRISA, South Africa; MGH, USA), as well as a single follow-up visit from enrolled participants. Using 16S rRNA gene sequencing-based categorization of community state type (CST) as the reference and multinomial mixed-effects logistic models, we evaluated the association of Amsel BV and Nugent BV with CST IV (including subtypes IV-A and IV-B) and tested for site-specific effects. Results: Amsel BV was significantly associated with CST IV-A and IV-B; however, the strength of association was significantly diminished at CAPRISA compared with MGH, pointing to site-specific assessment differences or underlying biological variation. Nugent BV yielded stronger associations with CST IV-A, and IV-B and showed no evidence of a site-specific interaction, indicating consistent performance across sites. Conclusions: These findings indicate that diagnostic performance for vaginal dysbiosis varies by framework: Amsel criteria are more susceptible to geographical site effects, whereas Nugent score demonstrates stronger and more site-agnostic associations. For clinical studies targeting vaginal dysbiosis, Nugent scoring and/or sequencing-based approaches should be prioritized for vaginal dysbiosis endpoint definition and stratification.

  • Open Access

    Cervicovaginal inflammation and HIV target cell activation in adolescent girls and young women with Chlamydia trachomatis infections

    by Smritee Dabee, Shaun Barnabas, Brian Kullin, Bart Versteeg, Nonhlanhla Mkhize, Etienne Muller, Venessa Maseko, David A Lewis, Janan Dietrich, Glenda Gray, et al.

    Background: Adolescent girls and young women (AGYW) in sub-Saharan Africa are disproportionately affected by Chlamydia trachomatis (CT) infections, a leading cause of pelvic inflammatory disease, infertility and increased HIV susceptibility. CT-induced genital inflammation disrupts mucosal barriers and activates HIV target cells, compounding immunological risks. We investigated CT infection in AGYW from two South African regions, focusing on genital inflammation and immune activation. Methods: An observational cohort of 298 sexually active AGYW (aged 16–22 years) from Cape Town and Johannesburg was enrolled. Participants in Johannesburg attended one visit, while those in Cape Town were followed longitudinally (6–8 months). Cytokine profiling of cervicovaginal samples assessed inflammatory responses, while cervical cytobrush-derived CD4+ T cells were analysed for CD38, Ki67 and C-C chemokine receptor type 5 expression. CT ompA genotyping examined strain diversity. Results: CT prevalence was 2.4-times higher in Cape Town (41.6%) than Johannesburg (17.4%). CT infection was associated with upregulated interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α, with responses appearing stronger in Johannesburg, although low CT cases at this site limited regional comparisons. Genotyping suggested regional variation: genovar D, predominant in Cape Town, was associated with lower interferon (IFN)-γ concentrations, whereas genovar E, more common in Johannesburg, was associated with higher IFN-γ concentrations. AGYW with CT infection across multiple visits did not exhibit elevated genital tract cytokine levels compared with those infected at a single visit. However, they showed increased activated cervical CD4+ T cells. Conclusions: CT-associated immune responses in AGYW appear to reflect a combination of pathogen diversity, regional context and host immune history.

  • Open Access

    Antimicrobial resistance profiles and genomic diversity of vaginal Prevotella bivia from South African women, including the first report of nimK

    by Kirsten Welp, Lynthia Paul, Anna-Ursula Happel, Linda-Gail Bekker, Remy Froissart, Tanya Pidwell, Katherine Gill, Heather B. Jaspan, Marie Vasse, Jo-Ann S. Passmore, et al.

    Objectives: To characterise the phenotypic and genotypic antimicrobial resistance (AMR) profiles and genomic diversity of Prevotella bivia isolates from South African women, and to compare these with publicly available whole genome assemblies.Methods: P. bivia were isolated from lateral vaginal wall swabs and identified using genus-specific primers and 16S rRNA gene sequencing. Phenotypic susceptibility to standard BV antibiotics (metronidazole, clindamycin) and other genitourinary antibiotics was determined by Etest. All isolates underwent Illumina MiSeq whole-genome sequencing to assess genomic diversity and AMR determinant presence, were analysed alongside publicly available assemblies.Results: 35 P. bivia isolates from 30 samples were sequenced. Resistance to metronidazole and clindamycin was low (2.9% and 8.6%), with MIC₉₀ values of 0.6 µg/mL and 0.22 µg/mL, respectively. Resistance to other antibiotics was lower (31-83%), and co-resistance to multiple antibiotic classes was common. Comparative genomic analysis of 33 high-quality genomes revealed low intra-sample diversity overall, although one sample harboured two distinct strains. In one study participant, there was evidence of strain persistence over eight weeks. South African strains showed phylogenetic separation from USA-derived strains. AMR gene determinants were identified, with most strains carrying tetQ (90.9%) and cfxA (72.7%), with the cfxA3/A4 variant associated with amoxicillin MICs. There was rare detection of ermF (3%) and nimK (3%), the latter being the first report of nimK in South Africa, which associated with a previously described Tn6456-like transposon and reduced metronidazole susceptibility.Conclusions: Vaginal P. bivia isolates from South African women exhibited low genomic diversity, with evidence of strain persistence and co-colonisation. Resistance metronidazole remains low, but nimK detection on a transposon highlights potential for AMR gene transfer, underscoring the need for continued monitoring of strain diversity and resistance.

  • Open Access

    Distinct Cervicovaginal Cytokine Signatures Associated with Reproductive Tract Infections and Vaginal Dysbiosis Across Diverse Settings

    by Micaela Lurie, Tania Crucitti, Musalula Sinkala, Ramla F. Tanko, Aina Harimanana, Katherine Gill, Linda-Gail Bekker, Janneke Hhm van de Wijgert, Bich-Tram Huynh, Camille Fortas, et al.

    Background: Reproductive tract infections (RTIs) and bacterial vaginosis (BV) are major causes of genital inflammation and reproductive morbidity, yet often remain undetected under syndromic management. We evaluated cervicovaginal cytokine signatures associated with RTIs and vaginal dysbiosis in women from South Africa, Madagascar, and Zimbabwe. Methods: Vaginal swabs from 676 non-pregnant, sexually-active women (18–35 years) were tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) , Trichomonas vaginalis (TV) , Mycoplasma genitalium (MG) , Candida spp., and BV by PCR and Nugent scoring. Cervicovaginal IL-1α, IL-1β, and IP-10 concentrations were measured by ELISA, and associations with RTIs and vaginal dysbiosis were assessed using multivariable regression and population attribution fraction analyses. Results: BV (Nugent 7–10) was the most prevalent (50.4%) and dominant contributor to elevated IL-1α and IL-1β, accounting for >60% of women with high cytokine levels. Intermediate vaginal microbiota (Nugent 4–6) showed similar inflammatory profiles and, with BV, was associated with reduced IP-10. NG was independently associated with elevated IL-1α and IL-1β, CT with elevated IL-1β and IP-10, TV with elevated IP-10, Candida spp. with elevations in all cytokines, while MG showed no independent associations. Most RTIs and vaginal dysbiosis were asymptomatic, with similar inflammatory profiles regardless of symptoms. Despite variation in baseline cytokine concentrations, infection-associated inflammatory signatures were consistent across countries. Conclusions: RTIs and vaginal dysbiosis elicited consistent inflammatory signatures across countries, with BV and intermediate microbiota driving much of the inflammatory burden. Their frequent occurrence in asymptomatic women highlights the potential of host-response biomarkers to identify otherwise undetected genital inflammation. Lay summary: Reproductive tract infections and bacterial vaginosis (BV; a common condition in which the normal protective bacteria in the vagina are replaced by a mix of other bacteria) are major causes of poor reproductive health, but many women have no symptoms and remain undiagnosed. In this study, we measured inflammatory proteins in vaginal samples from 676 women in South Africa, Madagascar, and Zimbabwe and examined how these markers were associated with infections and changes in the vaginal microbiota. We found that BV was the strongest driver of genital inflammation and that women with intermediate vaginal microbiota, often considered a transitional microbial state, showed similar inflammatory profiles. Different infections were associated with distinct inflammatory patterns, but many women with substantial inflammation had no symptoms. Importantly, these inflammatory responses were broadly similar across all three countries. Together, these findings highlight important limitations of symptom-based diagnosis and support the development of host-response diagnostics that can identify by reproductive tract infections and vaginal dysbiosis, including in women who would otherwise remain undiagnosed.

  • Open Access

    Genital Inflammatory Responses in Women Living with HIV Randomized to Copper or Levonorgestrel Intrauterine Contraceptives: A secondary analysis of a randomized trial

    by Anna-Ursula Happel, Jo-Ann S. Passmore, Musalula Sinkala, Shameem Z. Jaumdally, Hoyam Gamieldien, Nai-Chung Hu, Nontokozo Langwenya, Heidi E. Jones, Donald R. Hoover, Landon Myer, et al.

    Background: Intrauterine contraceptives (IUCs) are effective, but effects on genital inflammation among women living with HIV (WLHIV) by antiretroviral therapy (ART) use are unclear. We evaluated the longitudinal effects of copper IUC (CLIUC) and the levonorgestrel intrauterine system (LNGLIUS) on cervicovaginal cytokine profiles in a secondary analysis of a randomized trial ( NCT01721798 , 2013–2016). Methods: Cervicovaginal secretions were collected from 100 WLHIV (nonLART usersL=L48; ART usersL=L52) randomized 1:1 to ClZIUC or LNGlZIUS. TwentyLeight cytokines were measured prior to insertion and 3- and 6-months postLinsertion. Cytokine concentrations at each followLup visit were compared with baseline, using participant fixedLeffects models stratified by ART status. Results: At enrollment, nonLART users had higher average concentrations of most cytokines (21/28) than women using ART. Among non-ART users, IUC use was not associated with cytokine increases; only MCPL1 increased significantly at 3 months among CLIUC users (log 10 geometric mean ratio 0.77, 95%CI 0.38–1.17), while none increased with LNG-IUS use. Among ART users, C-IUC insertion resulted in broad and sustained cytokine increases at both 3 (16/28) and 6 months (15/28). At month 3, the largest increases in log 10 geometric mean were observed for IL-6 (1.04, 0.72-1.36), RANTES (0.97, 0.54-1.40), MCP-1 (0.71, 0.46-0.96), MIP-1α (0.66, 0.37-0.94), and G-CSF (0.63, 0.36-0.89), which was maintained until month 6. Cytokine changes following LNGLIUS insertion were minimal (IL-5, month 3). Conclusions: Among ART users, CLIUC is associated with increases in cervicovaginal cytokines, across functional classes. This supports LNGLIUS as a less inflammatory option for WLHIV to minimize genital immune activation.

  • Open Access

    Genomic Diversity of Vaginal Lactobacillus crispatus Prophages from South African Women

    by Adijat Ozohu Jimoh, Anika Chicken, Brandon Maust, Colin Feng, Seth Rakoff-Nahoum, Jo-Ann S. Passmore, Brian R. Kullin, Simona Kraberger, Fatima Aysha Hussain, Heather B. Jaspan, et al.

    Lactobacillus crispatus is widely associated with optimal sexual and reproductive health outcomes. While L. crispatus genomes commonly harbor prophages, little is known about their genomic diversity and potential inducibility by clinically relevant compounds. We induced and characterized four bacteriophages from four L. crispatus strains isolated from vaginal secretions of South African adolescents. Sequenced viral DNA from induced phages was assembled, and their respective genomes were annotated and compared to bacteriophage reference genomes. All the phage genomes range in size from 42.9 to 48.3 kbp. Of the four phages, UC101 and UC164 shared L. crispatus strains were exposed to physiological concentrations of copper ions and tenofovir, selected based on their common use by women in Africa and reported associations with altered vaginal bacterial community composition. The presence of phage-like particles following exposure to copper ions (2.0 × 10−6 M–3.0 × 10−6 M) and tenofovir (500 ng/mL) was observed by transmission electron microscopy, suggesting possible prophage activation under these conditions. This study provides new insights into the genomic diversity of inducible L. crispatus phages and presents hypothesis-generating evidence regarding their potential inducibility using copper ions and tenofovir.

  • Open Access

    High Prevalence and Genotypic Diversity of Persistent Chlamydia Trachomatis Infections Among South African Adolescent Girls and Young Women: A Tale of Two Cities

    by Smritee Dabee, Shaun Barnabas, Bart Versteeg, Brian Kullin, Shameem Z Jaumdally, Hoyam Gamieldien, Nonhlanhla Mkhize, Etienne Muller, Venessa Maseko, Katherine Gill, et al.

    Chlamydia trachomatis (CT) is the most common sexually transmitted bacterial infection globally, significantly affecting adolescent girls and young women (AGYW) in South Africa. This study investigated CT prevalence and genotypic diversity among 298 AGYW from Cape Town and Johannesburg, revealing an overall prevalence of 29.5%. Prevalence was higher in Cape Town (41.6%) compared to Johannesburg (17.4%; P < .0001). Genetic analysis identified 34 sequence types, including 15 novel variants. Longitudinal data highlighted frequent reinfections or persistent infections despite treatment. These findings underscore the importance of addressing CT's genetic diversity for improved reproductive health strategies and vaccine development.


  • Open Access

    Sialidase variability in Gardnerella : genetics, taxonomy, function, and clinical presentation

    by Marie Vasse, Nicola Mayrhofer, Valerie Masete, Jo-Ann S. Passmore, Hélène Jean-Pierre, Sylvain Godreuil, Rémy Froissart, Ignacio G. Bravo

    Bacterial vaginosis (BV) is the most common vaginal condition among women of reproductive age. Despite over six decades of research, the pathogenesis and etiology of BV remain largely unknown. Members of the Gardnerella genus are common components of the healthy vaginal microbiota, although their uncontrolled proliferation plays a key role in BV pathogenesis. Recent taxonomic revisions have highlighted extensive genetic and functional diversity among Gardnerella spp., but the relationship between genetics, taxonomy, and virulence remains elusive. Sialidases are key virulence factors in BV, degrading the protective epithelial mucus layer, facilitating colonization and releasing carbon and nitrogen sources. However, robust clinical evidence linking sialidases to increased BV risk remains limited. Here, we analyzed clinical Gardnerella isolates from BV-positive (75%) and BV-negative (25%) samples (n = 66) collected at the University Hospital of Montpellier, France. We inferred phylogenetic relationships, characterised the nanH sialidase gene repertoire, quantified in vitro sialidase activity, and evaluated antibiotic resistance profiles. Most isolates belonged to Gardnerella clades 1, 2, and 4 (63.6%, 19.7%, and 16.7%, respectively). The three nanH genes were unevenly distributed across clades: nanH1 was most common (∼80%), highly prevalent in clades 1-3; nanH2 was rare (6%); and nanH3 (∼38%) was predominantly found in clade 2 - typically co-occurring with nanH1 . Sialidase activity varied both between and within clades, and was only weakly associated with the nanH gene repertoire. Neither taxonomy nor sialidase-associated traits were reliable predictors of BV status, and we found no clear link between taxonomy and antibiotic resistance. Together, these results reveal substantial discordance in the genotype-phenotype relationship in Gardnerella , suggesting epigenetic, physiological and/or ecological modulation. Our findings highlight the need for a better understanding of bacterial physiology, plasticity, and ecology to explain microbial traits of clinical importance.